Glucagon-like Peptide-2 (GLP-2) Agonist Market, Global Outlook and Forecast 2022-2028
Teduglutide (brand names Gattex in the US and Revestive in Europe) is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome.
This report contains market size and forecasts of Glucagon-like Peptide-2 (GLP-2) Agonist in global, including the following market information:
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Glucagon-like Peptide-2 (GLP-2) Agonist companies in 2021 (%)
The global Glucagon-like Peptide-2 (GLP-2) Agonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gattex Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glucagon-like Peptide-2 (GLP-2) Agonist include Takeda Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glucagon-like Peptide-2 (GLP-2) Agonist manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Segment Percentages, by Type, 2021 (%)
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Segment Percentages, by Application, 2021 (%)
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Glucagon-like Peptide-2 (GLP-2) Agonist revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Glucagon-like Peptide-2 (GLP-2) Agonist revenues share in global market, 2021 (%)
Key companies Glucagon-like Peptide-2 (GLP-2) Agonist sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Glucagon-like Peptide-2 (GLP-2) Agonist sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Glucagon-like Peptide-2 (GLP-2) Agonist in global, including the following market information:
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Glucagon-like Peptide-2 (GLP-2) Agonist companies in 2021 (%)
The global Glucagon-like Peptide-2 (GLP-2) Agonist market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gattex Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glucagon-like Peptide-2 (GLP-2) Agonist include Takeda Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glucagon-like Peptide-2 (GLP-2) Agonist manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Segment Percentages, by Type, 2021 (%)
- Gattex
- Revestive
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Pharmacy
- Other
Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Glucagon-like Peptide-2 (GLP-2) Agonist revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Glucagon-like Peptide-2 (GLP-2) Agonist revenues share in global market, 2021 (%)
Key companies Glucagon-like Peptide-2 (GLP-2) Agonist sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Glucagon-like Peptide-2 (GLP-2) Agonist sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Takeda Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Glucagon-like Peptide-2 (GLP-2) Agonist Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST OVERALL MARKET SIZE
2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size: 2021 VS 2028
2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Glucagon-like Peptide-2 (GLP-2) Agonist Players in Global Market
3.2 Top Global Glucagon-like Peptide-2 (GLP-2) Agonist Companies Ranked by Revenue
3.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Companies
3.4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Companies
3.5 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Glucagon-like Peptide-2 (GLP-2) Agonist Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glucagon-like Peptide-2 (GLP-2) Agonist Players in Global Market
3.8.1 List of Global Tier 1 Glucagon-like Peptide-2 (GLP-2) Agonist Companies
3.8.2 List of Global Tier 2 and Tier 3 Glucagon-like Peptide-2 (GLP-2) Agonist Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Markets, 2021 & 2028
4.1.2 Gattex
4.1.3 Revestive
4.2 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue & Forecasts
4.2.1 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2022
4.2.2 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2023-2028
4.2.3 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
4.3 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales & Forecasts
4.3.1 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2022
4.3.2 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2023-2028
4.3.3 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
4.4 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Other
5.2 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue & Forecasts
5.2.1 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2022
5.2.2 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2023-2028
5.2.3 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
5.3 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales & Forecasts
5.3.1 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2022
5.3.2 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2023-2028
5.3.3 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
5.4 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2021 & 2028
6.2 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue & Forecasts
6.2.1 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2022
6.2.2 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2023-2028
6.2.3 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
6.3 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales & Forecasts
6.3.1 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2022
6.3.2 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2023-2028
6.3.3 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028
6.4.2 By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2028
6.4.3 US Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.4.4 Canada Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.4.5 Mexico Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028
6.5.2 By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2028
6.5.3 Germany Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.4 France Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.5 U.K. Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.6 Italy Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.7 Russia Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.8 Nordic Countries Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.9 Benelux Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028
6.6.2 By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2028
6.6.3 China Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.6.4 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.6.5 South Korea Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.6.6 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.6.7 India Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028
6.7.2 By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2028
6.7.3 Brazil Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.7.4 Argentina Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2028
6.8.3 Turkey Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.8.4 Israel Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.8.5 Saudi Arabia Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.8.6 UAE Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Takeda Pharmaceuticals
7.1.1 Takeda Pharmaceuticals Corporate Summary
7.1.2 Takeda Pharmaceuticals Business Overview
7.1.3 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Major Product Offerings
7.1.4 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Revenue in Global (2017-2022)
7.1.5 Takeda Pharmaceuticals Key News
8 GLOBAL GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST PRODUCTION CAPACITY, ANALYSIS
8.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Production Capacity, 2017-2028
8.2 Glucagon-like Peptide-2 (GLP-2) Agonist Production Capacity of Key Manufacturers in Global Market
8.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST SUPPLY CHAIN ANALYSIS
10.1 Glucagon-like Peptide-2 (GLP-2) Agonist Industry Value Chain
10.2 Glucagon-like Peptide-2 (GLP-2) Agonist Upstream Market
10.3 Glucagon-like Peptide-2 (GLP-2) Agonist Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glucagon-like Peptide-2 (GLP-2) Agonist Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Glucagon-like Peptide-2 (GLP-2) Agonist Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST OVERALL MARKET SIZE
2.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size: 2021 VS 2028
2.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Glucagon-like Peptide-2 (GLP-2) Agonist Players in Global Market
3.2 Top Global Glucagon-like Peptide-2 (GLP-2) Agonist Companies Ranked by Revenue
3.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Companies
3.4 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Companies
3.5 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Glucagon-like Peptide-2 (GLP-2) Agonist Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glucagon-like Peptide-2 (GLP-2) Agonist Players in Global Market
3.8.1 List of Global Tier 1 Glucagon-like Peptide-2 (GLP-2) Agonist Companies
3.8.2 List of Global Tier 2 and Tier 3 Glucagon-like Peptide-2 (GLP-2) Agonist Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size Markets, 2021 & 2028
4.1.2 Gattex
4.1.3 Revestive
4.2 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue & Forecasts
4.2.1 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2022
4.2.2 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2023-2028
4.2.3 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
4.3 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales & Forecasts
4.3.1 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2022
4.3.2 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2023-2028
4.3.3 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
4.4 By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Other
5.2 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue & Forecasts
5.2.1 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2022
5.2.2 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2023-2028
5.2.3 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
5.3 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales & Forecasts
5.3.1 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2022
5.3.2 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2023-2028
5.3.3 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
5.4 By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2021 & 2028
6.2 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue & Forecasts
6.2.1 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2022
6.2.2 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2023-2028
6.2.3 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
6.3 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales & Forecasts
6.3.1 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2022
6.3.2 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2023-2028
6.3.3 By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028
6.4.2 By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2028
6.4.3 US Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.4.4 Canada Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.4.5 Mexico Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028
6.5.2 By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2028
6.5.3 Germany Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.4 France Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.5 U.K. Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.6 Italy Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.7 Russia Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.8 Nordic Countries Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.5.9 Benelux Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028
6.6.2 By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2028
6.6.3 China Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.6.4 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.6.5 South Korea Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.6.6 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.6.7 India Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028
6.7.2 By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2028
6.7.3 Brazil Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.7.4 Argentina Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales, 2017-2028
6.8.3 Turkey Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.8.4 Israel Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.8.5 Saudi Arabia Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
6.8.6 UAE Glucagon-like Peptide-2 (GLP-2) Agonist Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Takeda Pharmaceuticals
7.1.1 Takeda Pharmaceuticals Corporate Summary
7.1.2 Takeda Pharmaceuticals Business Overview
7.1.3 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Major Product Offerings
7.1.4 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Revenue in Global (2017-2022)
7.1.5 Takeda Pharmaceuticals Key News
8 GLOBAL GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST PRODUCTION CAPACITY, ANALYSIS
8.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Production Capacity, 2017-2028
8.2 Glucagon-like Peptide-2 (GLP-2) Agonist Production Capacity of Key Manufacturers in Global Market
8.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 GLUCAGON-LIKE PEPTIDE-2 (GLP-2) AGONIST SUPPLY CHAIN ANALYSIS
10.1 Glucagon-like Peptide-2 (GLP-2) Agonist Industry Value Chain
10.2 Glucagon-like Peptide-2 (GLP-2) Agonist Upstream Market
10.3 Glucagon-like Peptide-2 (GLP-2) Agonist Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glucagon-like Peptide-2 (GLP-2) Agonist Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Glucagon-like Peptide-2 (GLP-2) Agonist in Global Market
Table 2. Top Glucagon-like Peptide-2 (GLP-2) Agonist Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Companies, 2017-2022
Table 5. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Companies, (K Units), 2017-2022
Table 6. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Product Type
Table 9. List of Global Tier 1 Glucagon-like Peptide-2 (GLP-2) Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glucagon-like Peptide-2 (GLP-2) Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2017-2022
Table 15. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2023-2028
Table 16. By Application – Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2017-2022
Table 20. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2023-2028
Table 21. By Region – Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2017-2022
Table 25. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2023-2028
Table 26. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2017-2022
Table 29. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2023-2028
Table 30. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2017-2022
Table 33. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2023-2028
Table 34. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2017-2022
Table 37. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2023-2028
Table 38. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2017-2022
Table 41. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2023-2028
Table 46. Takeda Pharmaceuticals Corporate Summary
Table 47. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product Offerings
Table 48. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Glucagon-like Peptide-2 (GLP-2) Agonist Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 50. Global Glucagon-like Peptide-2 (GLP-2) Agonist Capacity Market Share of Key Manufacturers, 2020-2022
Table 51. Global Glucagon-like Peptide-2 (GLP-2) Agonist Production by Region, 2017-2022 (K Units)
Table 52. Global Glucagon-like Peptide-2 (GLP-2) Agonist Production by Region, 2023-2028 (K Units)
Table 53. Glucagon-like Peptide-2 (GLP-2) Agonist Market Opportunities & Trends in Global Market
Table 54. Glucagon-like Peptide-2 (GLP-2) Agonist Market Drivers in Global Market
Table 55. Glucagon-like Peptide-2 (GLP-2) Agonist Market Restraints in Global Market
Table 56. Glucagon-like Peptide-2 (GLP-2) Agonist Raw Materials
Table 57. Glucagon-like Peptide-2 (GLP-2) Agonist Raw Materials Suppliers in Global Market
Table 58. Typical Glucagon-like Peptide-2 (GLP-2) Agonist Downstream
Table 59. Glucagon-like Peptide-2 (GLP-2) Agonist Downstream Clients in Global Market
Table 60. Glucagon-like Peptide-2 (GLP-2) Agonist Distributors and Sales Agents in Global Market
Table 1. Key Players of Glucagon-like Peptide-2 (GLP-2) Agonist in Global Market
Table 2. Top Glucagon-like Peptide-2 (GLP-2) Agonist Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Companies, 2017-2022
Table 5. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Companies, (K Units), 2017-2022
Table 6. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Glucagon-like Peptide-2 (GLP-2) Agonist Product Type
Table 9. List of Global Tier 1 Glucagon-like Peptide-2 (GLP-2) Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glucagon-like Peptide-2 (GLP-2) Agonist Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2017-2022
Table 15. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2023-2028
Table 16. By Application – Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2017-2022
Table 20. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2023-2028
Table 21. By Region – Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2017-2022
Table 25. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), 2023-2028
Table 26. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2017-2022
Table 29. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2023-2028
Table 30. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2017-2022
Table 33. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2023-2028
Table 34. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2017-2022
Table 37. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2023-2028
Table 38. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2017-2022
Table 41. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales, (K Units), 2023-2028
Table 46. Takeda Pharmaceuticals Corporate Summary
Table 47. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product Offerings
Table 48. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Glucagon-like Peptide-2 (GLP-2) Agonist Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 50. Global Glucagon-like Peptide-2 (GLP-2) Agonist Capacity Market Share of Key Manufacturers, 2020-2022
Table 51. Global Glucagon-like Peptide-2 (GLP-2) Agonist Production by Region, 2017-2022 (K Units)
Table 52. Global Glucagon-like Peptide-2 (GLP-2) Agonist Production by Region, 2023-2028 (K Units)
Table 53. Glucagon-like Peptide-2 (GLP-2) Agonist Market Opportunities & Trends in Global Market
Table 54. Glucagon-like Peptide-2 (GLP-2) Agonist Market Drivers in Global Market
Table 55. Glucagon-like Peptide-2 (GLP-2) Agonist Market Restraints in Global Market
Table 56. Glucagon-like Peptide-2 (GLP-2) Agonist Raw Materials
Table 57. Glucagon-like Peptide-2 (GLP-2) Agonist Raw Materials Suppliers in Global Market
Table 58. Typical Glucagon-like Peptide-2 (GLP-2) Agonist Downstream
Table 59. Glucagon-like Peptide-2 (GLP-2) Agonist Downstream Clients in Global Market
Table 60. Glucagon-like Peptide-2 (GLP-2) Agonist Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Type
Figure 2. Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Application
Figure 3. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028 (US$, Mn)
Figure 7. Glucagon-like Peptide-2 (GLP-2) Agonist Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Glucagon-like Peptide-2 (GLP-2) Agonist Revenue in 2021
Figure 9. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 10. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 11. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 13. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 14. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 16. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 17. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 18. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 19. US Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 24. Germany Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 25. France Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 33. China Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 37. India Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 39. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 40. Brazil Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 44. Turkey Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 48. Global Glucagon-like Peptide-2 (GLP-2) Agonist Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Glucagon-like Peptide-2 (GLP-2) Agonist by Region, 2021 VS 2028
Figure 50. Glucagon-like Peptide-2 (GLP-2) Agonist Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Type
Figure 2. Glucagon-like Peptide-2 (GLP-2) Agonist Segment by Application
Figure 3. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, 2017-2028 (US$, Mn)
Figure 7. Glucagon-like Peptide-2 (GLP-2) Agonist Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Glucagon-like Peptide-2 (GLP-2) Agonist Revenue in 2021
Figure 9. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 10. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 11. By Type - Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 13. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 14. By Application - Global Glucagon-like Peptide-2 (GLP-2) Agonist Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 16. By Region - Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 17. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 18. By Country - North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 19. US Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 24. Germany Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 25. France Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 33. China Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 37. India Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 39. By Country - South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 40. Brazil Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share, 2017-2028
Figure 44. Turkey Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Glucagon-like Peptide-2 (GLP-2) Agonist Revenue, (US$, Mn), 2017-2028
Figure 48. Global Glucagon-like Peptide-2 (GLP-2) Agonist Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Glucagon-like Peptide-2 (GLP-2) Agonist by Region, 2021 VS 2028
Figure 50. Glucagon-like Peptide-2 (GLP-2) Agonist Industry Value Chain
Figure 51. Marketing Channels
